Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glargine Plus Glulisine vs Sliding Scale Regular Insulin in Hospitalized T2D
NCT00394407Phase 4Completed
- Sponsor
- Emory University
- Start
- Sep 2005
- Primary completion
- Jun 2006
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine, insulin glulisine in type 2 diabetes mellitus (T2DM), hyperglycemia, sponsored by Emory University. Started Sep 2005; status: completed.
02
Drugs
insulin glargineinsulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)hyperglycemia
Beyond the preview
Go deeper on NCT00394407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00394407.